Ledger.

Professor, University of Newcastle

Professor David Durrheim

Coverage

Stories naming Professor David Durrheim. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Grant $7.5m

Vaxxas Awarded US$5 million Grant for Clinical Study of Measles and Rubella Vaccination

Vaxxas received a Gates Foundation grant to run first-in-human trials of its microneedle patch vaccine for measles and rubella, building on an earlier preclinical grant from the same funder.

Brandon BioCatalyst portfolio Wed 18 Mar 2020 VaxxasUniversity of NewcastleWestern Pacific Measles and Rubella Regional Verification CommissionGates FoundationProfessor David DurrheimDr David L Hoey

Also Brandon Capital portfolio

Something wrong? Tell us